Related references
Note: Only part of the references are listed.Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
Amanda J. Sales et al.
MOLECULAR NEUROBIOLOGY (2019)
A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems
Samuel T. Wilkinson et al.
DRUG DISCOVERY TODAY (2019)
Hemisphere-dependent Changes in mRNA Expression of GABAA Receptor Subunits and BDNF after Intra-prefrontal Cortex Allopregnanolone Infusion in Rats
Felipe Borges Almeida et al.
NEUROSCIENCE (2019)
Subregion-specific Protective Effects of Fluoxetine and Clozapine on Parvalbumin Expression in Medial Prefrontal Cortex of Chronically Isolated Rats
Nevena Todorovic et al.
NEUROSCIENCE (2019)
Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
Kenichi Fukumoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder
Sehrish Sayed et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Changes in the Prefrontal Glutamatergic and Parvalbumin Systems of Mice Exposed to Unpredictable Chronic Stress
Ryan Shepard et al.
MOLECULAR NEUROBIOLOGY (2018)
BDNF release and signaling are required for the antidepressant actions of GLYX-13
T. Kato et al.
MOLECULAR PSYCHIATRY (2018)
The Gamma-Aminobutyric Acid B Receptor in Depression and Reward
Laura H. Jacobson et al.
BIOLOGICAL PSYCHIATRY (2018)
Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine
Sriparna Ghosal et al.
BIOLOGICAL PSYCHIATRY (2018)
Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies
Francesc Artigas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
Manoela V. Fogaca et al.
NEUROPHARMACOLOGY (2018)
Regulation of somatostatin receptor 2 in the context of antidepressant treatment response in chronic mild stress in rat
Agata Faron-Gorecka et al.
PSYCHOPHARMACOLOGY (2018)
An Emerging Circuit Pharmacology of GABAA Receptors
Elif Engin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Long-Term Stress Disrupts the Structural and Functional Integrity of GABAergic Neuronal Networks in the Medial Prefrontal Cortex of Rats
Boldizsar Czeh et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
PV Interneurons: Critical Regulators of E/I Balance for Prefrontal Cortex-Dependent Behavior and Psychiatric Disorders
Brielle R. Ferguson et al.
FRONTIERS IN NEURAL CIRCUITS (2018)
Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis
Kate E. M. Godfrey et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
Samantha Meltzer-Brody et al.
LANCET (2018)
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
Jose A. Crippa et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cannabinoids in depressive disorders
Ewa Poleszak et al.
LIFE SCIENCES (2018)
Comparison of rapid and long-lasting antidepressant effects of negative modulators of α5-containing GABAA receptors and (R)-ketamine in a chronic social defeat stress model
Zhongwei Xiong et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2018)
Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression
Mario Stampanoni Bassi et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Central Neuropeptide Y Plays an Important Role in Mediating the Adaptation Mechanism Against Chronic Stress in Male Rats
Yu Yang et al.
ENDOCRINOLOGY (2018)
Decrease in somatostatin-positive cell density in the amygdala of females with major depression
Gaelle Douillard-Guilloux et al.
DEPRESSION AND ANXIETY (2017)
Electron Microscopic Analysis of Hippocampal Axo-Somatic Synapses in a Chronic Stress Model for Depression
David Csabai et al.
HIPPOCAMPUS (2017)
Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state
T. Fuchs et al.
MOLECULAR PSYCHIATRY (2017)
Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality
Thomas D. Prevot et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression
Stephen J. Kanes et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2017)
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
Stephen Kanes et al.
LANCET (2017)
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors
T. Bakas et al.
PHARMACOLOGICAL RESEARCH (2017)
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
Alline C. Campos et al.
FRONTIERS IN PHARMACOLOGY (2017)
The potential efficacy of GABAB antagonists in depression
Robert C. Alexander
CURRENT OPINION IN PHARMACOLOGY (2017)
A Negative Allosteric Modulator for alpha 5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice
Panos Zanos et al.
ENEURO (2017)
Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives
Corey Fee et al.
BIOLOGICAL PSYCHIATRY (2017)
Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking α2-containing GABAA receptors
Rebecca S. Benham et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
How do antidepressants work? New perspectives for refining future treatment approaches
Catherine J. Harmer et al.
LANCET PSYCHIATRY (2017)
Ketamine Increases the Function of γ-Aminobutyric Acid Type A Receptors in Hippocampal and Cortical Neurons
Dian-Shi Wang et al.
ANESTHESIOLOGY (2017)
Prefrontal cortex GABAergic deficits and circuit dysfunction in the pathophysiology and treatment of chronic stress and depression
Sriparna Ghosal et al.
CURRENT OPINION IN BEHAVIORAL SCIENCES (2017)
Why is depression more common among women than among men?
Christine Kuehner
LANCET PSYCHIATRY (2017)
Chronic stress affects the number of GABAergic neurons in the orbitofrontal cortex of rats
Zsofia Varga et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
M. S. Milak et al.
MOLECULAR PSYCHIATRY (2016)
Chronic mild stress alters the somatostatin receptors in the rat brain
A. Faron-Gorecka et al.
PSYCHOPHARMACOLOGY (2016)
Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment
Zhen Ren et al.
BIOLOGICAL PSYCHIATRY (2016)
Chronic Stress Increases Prefrontal Inhibition: A Mechanism for Stress-Induced Prefrontal Dysfunction
Jessica M. McKlveen et al.
BIOLOGICAL PSYCHIATRY (2016)
DREADD in Parvalbumin Interneurons of the Dentate Gyrus Modulates Anxiety, Social Interaction and Memory Extinction
D. Zou et al.
CURRENT MOLECULAR MEDICINE (2016)
A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
Michael E. Thase et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy
Marc J. Dubin et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
Somatostatin-expressing neurons in cortical networks
Joanna Urban-Ciecko et al.
NATURE REVIEWS NEUROSCIENCE (2016)
GABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits
Robin Tremblay et al.
NEURON (2016)
Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures
Ashley E. Lepack et al.
NEUROPHARMACOLOGY (2016)
SENSITIVITY OF THE PREFRONTAL GABAergic SYSTEM TO CHRONIC STRESS IN MALE AND FEMALE MICE: RELEVANCE FOR SEX DIFFERENCES IN STRESS-RELATED DISORDERS
Ryan Shepard et al.
NEUROSCIENCE (2016)
Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABA(A) and GABA(B) receptors
Priscila B. Rosa et al.
PHARMACOLOGICAL REPORTS (2016)
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
Angelica Pupin Schiavon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Impaired GABA synthesis, uptake and release are associated with depression-like behaviors induced by chronic mild stress
K. Ma et al.
TRANSLATIONAL PSYCHIATRY (2016)
Sex-Dependent Anti-Stress Effect of an α5 Subunit Containing GABAA Receptor Positive Allosteric Modulator
Sean C. Piantadosi et al.
FRONTIERS IN PHARMACOLOGY (2016)
Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder
Chadi G. Abdallah et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Depression of Excitatory Synapses onto Parvalbumin Interneurons in the Medial Prefrontal Cortex in Susceptibility to Stress
Zinaida Perova et al.
JOURNAL OF NEUROSCIENCE (2015)
Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes
J. A. Brown et al.
MOLECULAR PSYCHIATRY (2015)
Rapid antidepressants stimulate the decoupling of GABAB receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3η
E. R. Workman et al.
MOLECULAR PSYCHIATRY (2015)
Somatostatin, neuronal vulnerability and behavioral emotionality
L. C. Lin et al.
MOLECULAR PSYCHIATRY (2015)
Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors
Jonathan Fischell et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants
Alan L. Pehrson et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Chronic Stress Reduces the Number of GABAergic Interneurons in the Adult Rat Hippocampus, Dorsal-Ventral and Region-Specific Differences
Boldizsar Czeh et al.
HIPPOCAMPUS (2015)
BDNF Release Is Required for the Behavioral Actions of Ketamine
Ashley E. Lepack et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
W. Zhou et al.
EUROPEAN PSYCHIATRY (2014)
Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings
G. Northoff et al.
MOLECULAR PSYCHIATRY (2014)
Opposing Effects of Acute versus Chronic Blockade of Frontal Cortex Somatostatin-Positive Inhibitory Neurons on Behavioral Emotionality in Mice
Amelie Soumier et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Cannabinoid CB1 receptors in rat medial prefrontal cortex are colocalized with calbindin but not parvalbumin- and calretinin-positive GABA-ergic neurons
Krzysztof Wędzony et al.
Pharmacological Reports (2014)
Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: An 11.7 T 1H-MRS study in rats
Shane A. Perrine et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?
Shannon K. Crowley et al.
PSYCHOPHARMACOLOGY (2014)
Chronic stress alters inhibitory networks in the medial prefrontal cortex of adult mice
Javier Gilabert-Juan et al.
BRAIN STRUCTURE & FUNCTION (2013)
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
Alline C. Campos et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
The Ability of BDNF to Modify Neurogenesis and Depressive-Like Behaviors Is Dependent upon Phosphorylation of Tyrosine Residues 365/367 in the GABAA-Receptor γ2 Subunit
Mansi Vithlani et al.
JOURNAL OF NEUROSCIENCE (2013)
New insights into the classification and nomenclature of cortical GABAergic interneurons
Javier DeFelipe et al.
NATURE REVIEWS NEUROSCIENCE (2013)
mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling
E. R. Workman et al.
NEUROPHARMACOLOGY (2013)
THE DIFFERENTIAL EFFECTS OF ACUTE VS. CHRONIC STRESS AND THEIR COMBINATION ON HIPPOCAMPAL PARVALBUMIN AND INDUCIBLE HEAT SHOCK PROTEIN 70 EXPRESSION
D. Filipovic et al.
NEUROSCIENCE (2013)
Serotonin modulation of cortical neurons and networks
Pau Celada et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2013)
Decreased mRNA and Protein Expression of BDNF, NGF, and their Receptors in the Hippocampus from Suicide: An Analysis in Human Postmortem Brain
Ritabrata Banerjee et al.
CLINICAL MEDICINE INSIGHTS- PATHOLOGY (2013)
Brain-Derived Neurotrophic Factor Signaling and Subgenual Anterior Cingulate Cortex Dysfunction in Major Depressive Disorder
Adam Tripp et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Anterior Cingulate Cortex γ-Aminobutyric Acid in Depressed Adolescents
Vilma Gabbay et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Fine-tuning of defensive behaviors in the dorsal periaqueductal gray by atypical neurotransmitters
M. V. Fogaca et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2012)
5-HT1A Receptor Agonists Enhance Pyramidal Cell Firing in Prefrontal Cortex Through a Preferential Action on GABA Interneurons
Laia Llado-Pelfort et al.
CEREBRAL CORTEX (2012)
Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study
Matthew J. Taylor et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression
J-P Guilloux et al.
MOLECULAR PSYCHIATRY (2012)
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine- induced psychopathology
J. M. Stone et al.
MOLECULAR PSYCHIATRY (2012)
Anxiety and depression: Mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes
Kiersten S. Smith et al.
NEUROPHARMACOLOGY (2012)
METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONIST 2-METHYL-6-(PHENYLETHYNYL)PYRIDINE PRODUCES ANTIDEPRESSANT EFFECTS IN RATS: ROLE OF BRAIN-DERIVED NEUROTROPHIC FACTOR
C. Y. Liu et al.
NEUROSCIENCE (2012)
Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients
Javier Gilabert-Juan et al.
NEUROSCIENCE LETTERS (2012)
Neuropeptide Y: Identification of a novel rat mRNA splice-variant that is downregulated in the hippocampus and the prefrontal cortex of a depression-like model
Philippe A. Melas et al.
PEPTIDES (2012)
Alprazolam for depression
Harm van Marwijk et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Antidepressant-like properties of α2-containing GABAA receptors
Isabel Vollenweider et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
GABAA Receptor Subtype-Selective Modulators. I. α2/α3-Selective Agonists as Non-Sedating Anxiolytics
John R. Atack
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Three Groups of Interneurons Account for Nearly 100% of Neocortical GABAergic Neurons
Bernardo Rudy et al.
DEVELOPMENTAL NEUROBIOLOGY (2011)
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders
Etienne Sibille et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
A Post Hoc Analysis of the Effect of Nightly Administration of Eszopiclone and a Selective Serotonin Reuptake Inhibitor in Patients With Insomnia and Anxious Depression
Maurizio Fava et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Recruitment of Prefrontal Cortical Endocannabinoid Signaling by Glucocorticoids Contributes to Termination of the Stress Response
Matthew N. Hill et al.
JOURNAL OF NEUROSCIENCE (2011)
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist
J. R. Atack et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
The GABAergic deficit hypothesis of major depressive disorder
B. Luscher et al.
MOLECULAR PSYCHIATRY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Uwe Rudolph et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Reduced somatostatin in subgenual anterior cingulate cortex in major depression
Adam Tripp et al.
NEUROBIOLOGY OF DISEASE (2011)
Different pattern of changes in calcium binding proteins immunoreactivity in the medial prefrontal cortex of rats exposed to stress models of depression
Monika Zadrozna et al.
PHARMACOLOGICAL REPORTS (2011)
The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS
Gerald W. Valentine et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2011)
Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusions
Michelle Yeung et al.
PSYCHOPHARMACOLOGY (2011)
Deficits in GABAB receptor system in schizophrenia and mood disorders: A postmortem study
S. Hossein Fatemi et al.
SCHIZOPHRENIA RESEARCH (2011)
Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression
Mauricio Nin
Frontiers in Endocrinology (2011)
Effect of Acute Psychological Stress on Prefrontal GABA Concentration Determined by Proton Magnetic Resonance Spectroscopy
Gregor Hasler et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
γ-Aminobutyric Acid-Type A Receptor Deficits Cause Hypothalamic-Pituitary-Adrenal Axis Hyperactivity and Antidepressant Drug Sensitivity Reminiscent of Melancholic Forms of Depression
Qiuying Shen et al.
BIOLOGICAL PSYCHIATRY (2010)
Reduced Density of Calbindin Immunoreactive GABAergic Neurons in the Occipital Cortex in Major Depression: Relevance to Neuroimaging Studies
Dorota Maciag et al.
BIOLOGICAL PSYCHIATRY (2010)
Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression
Beata Karolewicz et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Alterations in hippocampal calcium-binding neurons induced by stress models of depression: a preliminary assessment
Barbara Nowak et al.
PHARMACOLOGICAL REPORTS (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake
Graziano Pinna et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression
Esra Kucukibrahimoglu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
A Discrete GABAergic Relay Mediates Medial Prefrontal Cortical Inhibition of the Neuroendocrine Stress Response
Jason J. Radley et al.
JOURNAL OF NEUROSCIENCE (2009)
In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA Receptor α5 Subtype-Selective Inverse Agonist
John R. Atack et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis
Sarah A. Hewitt et al.
NATURE NEUROSCIENCE (2009)
Bipolar and major depressive disorder: Neuroimaging the develop mental-degenerative divide
Jonathan Savitz et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors
Elif Engin et al.
PSYCHOPHARMACOLOGY (2009)
Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression
T. A. Klempan et al.
MOLECULAR PSYCHIATRY (2009)
Posterior Hippocampal Volumes Are Associated with Remission Rates in Patients with Major Depressive Disorder
Glenda M. MacQueen et al.
BIOLOGICAL PSYCHIATRY (2008)
S-ketamine and GABA-A-receptor interaction in humans: an exploratory study with I-123-iomazenil SPECT
Alexander Heinze et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia
Tammy J. Sajdyk et al.
JOURNAL OF NEUROSCIENCE (2008)
ANXIOLYTIC AND ANTIDEPRESSANT EFFECTS OF INTRACEREBROVENTRICULARLY ADMINISTERED SOMATOSTATIN: BEHAVIORAL AND NEUROPHYSIOLOGICAL EVIDENCE
E. Engin et al.
NEUROSCIENCE (2008)
The neuropeptide YY1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice
Rose-Marie Karlsson et al.
PSYCHOPHARMACOLOGY (2008)
Fluoxetine partly exerts its actions through GABA:: A neurochemical evidence
M. Zafer Goren et al.
NEUROCHEMICAL RESEARCH (2007)
Patterns of gene expression in the limbic system of suicides with and without major depression
A. Sequeira et al.
MOLECULAR PSYCHIATRY (2007)
Neurosteroid synthesis-mediated regulation of GABAA receptors:: Relevance to the ovarian cycle and stress
Jamie Maguire et al.
JOURNAL OF NEUROSCIENCE (2007)
GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression
Grazyna Rajkowska et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy
Gregor Hasler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Low plasma BDNF is associated with suicidal behavior in major depression
Yong-Ku Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care
Michael Bauer et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2007)
Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons
Elisa L. Hill et al.
JOURNAL OF NEUROPHYSIOLOGY (2007)
GABA(A) receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: Possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders
Kinzo Matsumoto et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2007)
Allopregnanolone reduces immobility in the forced swimming test and increases the firing rate of lateral septal neurons through actions on the GABA(A) receptor in the rat
Juan Francisco Rodriguez-Landa et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult mate rats
Gaelle Naert et al.
PSYCHONEUROENDOCRINOLOGY (2007)
Inhibitory effect of somatostatin on inflammation and nociception
Erika Pinter et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents
G. Nowak et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder
M Fava et al.
BIOLOGICAL PSYCHIATRY (2006)
Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake
Graziano Pinna et al.
PSYCHOPHARMACOLOGY (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression
PV Choudary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram
G Nikisch et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
GABAA receptor γ2 subunit knockdown mice have enhanced anxiety-like behaviour but unaltered hypnotic response to benzodiazepines -: art. no. 30
D Chandra et al.
BMC NEUROSCIENCE (2005)
Mechanisms of somatostatin-evoked responses in neurons of the rat lateral amygdala
S Meis et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression
JF Cryan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
GABA(B) receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent
DA Slattery et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE)
MA Diana et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression:: preliminary evidence for association with preproNPY gene polymorphism
M Heilig et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2004)
Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat
V Uzunova et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Dysregulation in the suicide brain:: mRNA expression of corticotropin-releasing hormone receptors and GABAA receptorsubunits in frontal cortical brain region
Z Merali et al.
JOURNAL OF NEUROSCIENCE (2004)
Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor
Z Bhagwagar et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABAA receptor phosphorylation, activity, and cell-surface stability
JN Jovanovic et al.
JOURNAL OF NEUROSCIENCE (2004)
Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel
SA Carlton et al.
PAIN (2004)
Molecular evolution of NPY receptor subtypes
D Larhammar et al.
NEUROPEPTIDES (2004)
In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors
MV Puig et al.
CEREBRAL CORTEX (2004)
Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression
G Sanacora et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Genetic and pharmacological evidence of a role for GABAB receptors in the modulation of anxiety- and antidepressant-like behavior
C Mombereau et al.
NEUROPSYCHOPHARMACOLOGY (2004)
SGS742:: the first GABAB receptor antagonist in clinical trials
W Froestl et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Expression of Serotonin1A and Serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex
N Santana et al.
CEREBRAL CORTEX (2004)
Interneurons of the neocortical inhibitory system
H Markram et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Variations in maternal care alter GABAA receptor subunit expression in brain regions associated with fear
C Caldji et al.
NEUROPSYCHOPHARMACOLOGY (2003)
GABAB receptor antagonist CGP-36742 enhances somatostatin release in the rat hippocampus in vivo and in vitro
G Nyitrai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Somatostatin directly inhibits substantia gelatinosa neurons in adult rat spinal dorsal horn in vitro
N Jiang et al.
NEUROSCIENCE RESEARCH (2003)
Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects
Y Dwivedi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants
E Shimizu et al.
BIOLOGICAL PSYCHIATRY (2003)
NPY attenuates positive cortical DC-potential shift upon food intake in man
M Hallschmid et al.
PSYCHONEUROENDOCRINOLOGY (2003)
Fluoxetine increases GABAA receptor activity through a novel modulatory site
RT Robinson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
GABAB receptor mRNA in the raphe nuclei:: co-expression with serotonin transporter and glutamic acid decarboxylase
J Serrats et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Low CSF somatostatin associated with response to nimodipine in patents with affective illness
MA Frye et al.
BIOLOGICAL PSYCHIATRY (2003)
Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain
X Wang et al.
NEUROSCIENCE (2003)
Neuropeptide Y (NPY) and depression: From animal studies to the human condition
JP Redrobe et al.
LIFE SCIENCES (2002)
Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins
CL Beasley et al.
BIOLOGICAL PSYCHIATRY (2002)
The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test
JP Redrobe et al.
NEUROPSYCHOPHARMACOLOGY (2002)
A new benzodiazepine pharmacology
H Mohler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia
D Cotter et al.
BIOLOGICAL PSYCHIATRY (2002)
Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex:: Involvement of serotonin-1A, GABAA, and glutamate receptors
P Celada et al.
JOURNAL OF NEUROSCIENCE (2001)
The socially-isolated mouse:: a model to study the putative role of allopregnanolone and 5α-dihydroprogesterone in psychiatric disorders
A Guidotti et al.
BRAIN RESEARCH REVIEWS (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Corticosterone exerts site-specific and state-dependent effects in prefrontal cortex and amygdala on regulation of adrenocorticotropic hormone, insulin and fat depots
SF Akana et al.
JOURNAL OF NEUROENDOCRINOLOGY (2001)
Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation
E Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Variations in maternal care in infancy regulate the development of stress reactivity
C Caldji et al.
BIOLOGICAL PSYCHIATRY (2000)
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression
A Thorsell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice
C Viollet et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
GABAB-RI receptors in serotonergic neurons:: effects of baclofen on 5-HT output in rat brain
MT Abellán et al.
NEUROREPORT (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Antidepressant-like effect of the neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one in mice forced swim test
RT Khisti et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats
K Heese et al.
NEUROPHARMACOLOGY (2000)
Share Paper
